Heron Therapeutics Expects 2025 Sales Of $153M-$163M Versus Consensus Of $160.633M
Benzinga2025-02-27
Financial Guidance for 2025
Item
2025 Full-Year Guidance for Net Revenue and Adjusted EBITDA
(in millions)
Net Revenue
$153.0
to
$163.0
Adjusted EBITDA
$0.0
to
$8.0
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments